Skip to main content
Year archive

ADALTA LIMITED — 2021 filings

All 71 regulatory filings released by ADALTA LIMITED (1AD) in 2021, sourced directly from the official regulator.

71 Filings
2021 Period
2021 filings (71)
Filing Released Lang
Change in substantial holding 2 pages 491.1KB
Major Shareholding Notification
2021-12-23 English
Entitlement Offer - Letter to shareholders 3 pages 69.1KB
Capital/Financing Update
2021-12-22 English
Entitlement Offer - Letter to Ineligible Shareholders 1
Capital/Financing Update
2021-12-22 English
Entitlement Offer Booklet 40 pages 9.6MB
Capital/Financing Update
2021-12-22 English
Cleansing Notice - Entitlement Offer 2 pages 402.9KB
Capital/Financing Update
2021-12-22 English
Change in substantial holding 3 pages 143.9KB
Regulatory Filings
2021-12-21 English
Application for quotation of securities - 1AD 6 pages 27.5KB
Share Issue/Capital Change
2021-12-20 English
Cleansing Notice - Placement 1 page 373.8KB
Capital/Financing Update
2021-12-20 English
Proposed issue of securities - 1AD 7 pages 32.6KB
Capital/Financing Update
2021-12-14 English
Proposed issue of securities - 1AD 5 pages 28.0KB
Capital/Financing Update
2021-12-14 English
Placement raises $3.75million 4 pages 316.8KB
Capital/Financing Update
2021-12-14 English
Cash Position and Corporate Presentation 68 pages 9.2MB
Investor Presentation
2021-12-14 English
Reinstatement to Quotation 1 page 88.9KB
Regulatory Filings
2021-12-14 English
Cleansing Notice - Entitlement Offer 3 pages 405.3KB
Capital/Financing Update
2021-12-14 English
Letter to Optionholders 2 pages 421.7KB
Capital/Financing Update
2021-12-14 English
Voluntary Suspension 2 pages 1.1MB
Capital/Financing Update
2021-12-13 English
Trading Halt 2 pages 430.8KB
Capital/Financing Update
2021-12-09 English
Inhaled AD-214 passes first development milestone 2 pages 248.6KB
Capital/Financing Update
2021-12-08 English
Notification regarding unquoted securities - 1AD 7 pages 29.4KB
Share Issue/Capital Change
2021-12-02 English
Change in Director Interest Notice x 4 12 pages 373.3KB
Director's Dealing
2021-12-02 English
AGM presentations & first iCAR-T data 25 pages 3.9MB
AGM Information
2021-11-28 English
Results of Annual General Meeting 4 pages 245.5KB
Declaration of Voting Results & Voting Rights Announcements
2021-11-28 English
Application for quotation of securities - 1AD 6 pages 27.7KB
Capital/Financing Update
2021-11-18 English
Cleansing Notice under Section 708A 1 page 944.6KB
Share Issue/Capital Change
2021-11-18 English
Second US patent for AD-214 2 pages 232.8KB
Regulatory Filings
2021-11-17 English
Notification of cessation of securities - 1AD 4 pages 24.2KB
Share Issue/Capital Change
2021-11-16 English
Change in Director Interest Notice x 2 (PM & RP) 6 pages 319.0KB
Director's Dealing
2021-11-16 English
Spark Plus engaged for SE Asia IR - shares in lieu of fees 2 pages 234.8KB
Capital/Financing Update
2021-11-10 English
Proposed issue of securities - 1AD 5 pages 27.7KB
Capital/Financing Update
2021-11-10 English
R&D Tax Incentive Refund received 2 pages 331.5KB
Regulatory Filings
2021-11-07 English
Jobkeeper s323DB Notice 1 page 30.5KB
Regulatory Filings
2021-10-28 English
Virtual Meeting Voting and Registration Guide 5 pages 914.8KB
AGM Information
2021-10-28 English
Notice of Annual General Meeting/Proxy Form 27 pages 793.7KB
AGM Information
2021-10-28 English
Change of Director's Interest Notice 3 pages 260.8KB
Director's Dealing
2021-10-27 English
Company Presentation - AusBiotech and Bio-Europe 28 pages 7.2MB
Investor Presentation
2021-10-21 English
Quarterly Appendix 4C and Activities Report 11 pages 432.0KB
Interim / Quarterly Report
2021-10-13 English
BTB funding transferred to AD-214 inhalation program 3 pages 335.0KB
Capital/Financing Update
2021-10-06 English
Notification of Date of 2021 AGM 2 pages 295.2KB
AGM Information
2021-10-03 English
New pre-clinical data presented at Boston conference 27 pages 10.8MB
Investor Presentation
2021-09-26 English
Corporate overview and IRD Invest 2021 presentation 62 pages 12.8MB
Investor Presentation
2021-09-20 English
$4.0M Non-Dilutive Financing with Victorian Government 2 pages 318.9KB
Capital/Financing Update
2021-09-19 English
Preliminary Final Report 2 pages 225.0KB
Earnings Release
2021-08-26 English
Annual Report to shareholders 56 pages 3.1MB
Annual Report
2021-08-26 English
Appendix 4G and Corporate Governance Statement 30 pages 600.4KB
Regulatory Filings
2021-08-26 English
Carina collaboration webinar presentation 18 pages 3.0MB
Investor Presentation
2021-08-24 English
CAR-T collaboration with Carina Biotech 4 pages 405.9KB
Capital/Financing Update
2021-08-23 English
Quarterly Appendix 4C and Activities Report 11 pages 417.9KB
Interim / Quarterly Report
2021-07-27 English
Notification of cessation of securities - 1AD 4 pages 24.3KB
Share Issue/Capital Change
2021-07-20 English
AD-214 pathway to IPF efficacy studies 8 pages 395.5KB
Capital/Financing Update
2021-07-18 English
Webinar and presentation on AD-214 strategy 28 pages 2.0MB
Investor Presentation
2021-07-18 English
Change in Director Interest Notice x 4 13 pages 326.7KB
Director's Dealing
2021-07-06 English
Application for quotation of securities - 1AD 6 pages 27.7KB
Share Issue/Capital Change
2021-07-01 English
Operations Update & Cleansing Notice 4 pages 477.0KB
Capital/Financing Update
2021-07-01 English
Notification of cessation of securities - 1AD 4 pages 232.1KB
Regulatory Filings
2021-07-01 English
AdAlta secures AD-214 resupply 2 pages 325.3KB
Capital/Financing Update
2021-06-30 English
R&D Tax Incentive Facility 2 pages 846.9KB
Capital/Financing Update
2021-06-24 English
Notification of Expiry of Listed Options - Correction 2 pages 842.8KB
Capital/Financing Update
2021-06-10 English
Notification of Expiry of Listed Options 4 pages 1.2MB
Share Issue/Capital Change
2021-06-06 English
AdAlta corporate presentation, upcoming events 44 pages 11.4MB
Investor Presentation
2021-06-02 English
GE Healthcare collaboration advances to next stage 3 pages 369.2KB
Capital/Financing Update
2021-05-23 English
AdAlta granted Japanese patent for AD-214 2 pages 319.1KB
Regulatory Filings
2021-05-18 English
CSO presentation at ILD Drug Development Summit 26 pages 10.5MB
Investor Presentation
2021-04-27 English
Quarterly Appendix 4C and Activities Report 10 pages 397.8KB
Interim / Quarterly Report
2021-04-19 English
Mutiple Dose Part Of Ad-214 Phase I Trial Commenced 2 pages 317.7KB
Regulatory Filings
2021-04-18 English
Appendix 3G 13 pages 276.8KB
Share Issue/Capital Change
2021-03-31 English
AdAlta Corporate Overview March 2021 38 pages 10.5MB
Investor Presentation
2021-03-21 English
Investor briefing-AD-214 top line single dose safety results 35 pages 11.2MB
Investor Presentation
2021-03-09 English
AdAlta to host investor briefing 10 March 2 pages 299.6KB
Regulatory Filings
2021-02-28 English
Appendix 4D and Interim Financial Report 21 pages 645.4KB
Interim / Quarterly Report
2021-02-24 English
FDA Orphan Drug Designation for AD-214 2 pages 294.2KB
Regulatory Filings
2021-02-23 English
Quarterly Appendix 4C and Activities Report 9 pages 446.0KB
Interim / Quarterly Report
2021-01-27 English